A New Drug for PAH: Clinical Pharmacology of Ambrisentan

In June 2007, the FDA approved ambrisentan (LETAIRIS) for the once-daily treatment of PAH to improve exercise capacity and delay clinical worsening.

Ambrisentan, a diphenyl propionic acid derivative ( Figure 1. PubChem CID:6918493), represents a valuable addition to the treatment alternatives for this orphan disease, which include prostacyclin (Flolan), inhaled nitric oxide, iloprost (a prostacyclin analog), sildenafil (a PDE5 inhibitor), and conventional Ca++ channel blockers (e.g., verapamil and nifedipine). Ambrisentan is orally active and similar to an existing drug, bosentan;[5] both are competitive inhibitors of endothelin receptors and are termed endothelin receptor antagonists (ERAs). However, bosentan lacks the receptor selectivity of ambrisentan. Ambrisentan exhibits ∼100-fold greater selectivity for endothelin receptor A (ETA) as compared to endothelin receptor B (ETB) [Ki = 0.6 nM for the human ETA receptor, 49 nM for the ETB receptor].[4] This moderate selectivity for the ET receptor may provide therapeutic advantages compared to bosentan. A common adverse effect of ERAs is the propensity to impair liver function in some patients. Thus, ambrisentan is not recommended for use in patients with moderate or severe hepatic impairment since it may cause additional liver damage.[6] Liver aminotransferase enzymes (ALT and AST) must be measured before initiation of therapy and at least monthly thereafter during therapy. The drug is an FDA category X pregnancy drug and is contraindicated in women who are or who may become pregnant. It is not known whether the drug is secreted in milk, therefore nursing mothers should not breastfeed while receiving the drug. Because of the risks of liver injury and birth defects, ambrisentan is only available through the Letairis Education and Access Program (LEAP); only prescribers and pharmacies registered with LEAP may prescribe and dispense the drug, and only patients enrolled in and meeting all conditions of LEAP may receive the drug (for enrollment information, call 866-663-5327).

Figure 1.  (click image to zoom)

Adult dosing is initiated with 5 mg once daily, and if tolerated, dosing is increased to 10 mg once daily. Although early clinical trials showed no significant differences in beneficial effects using different doses of ambrisentan (1-10 mg) for patients with PAH,[7] the results of two recent clinical trials, ARIES-1 and ARIES-2, showed a dose-dependent improvement in 6-minute walk distance with once a day ambrisentan after 12 weeks. The absolute bioavailability of ambrisentan in humans is unknown, but is ∼90% in dogs.[7a] Bioavailability is unaffected by food. The drug is rapidly absorbed after oral administration with peak plasma concentrations occurring between 1.7 and 3.3 hours. The terminal half-life is about 15 hours, but after long-term daily dosing the effective half-life is about 9 hours.[49] At steady-state, mean trough concentrations of drug are ∼15% of mean peak concentrations. The drug is highly bound to plasma proteins and elimination is primarily by non-renal pathways. In vitro data indicate ambrisentan is a potential substrate of P-glycoprotein (P-gp), the Organic Anion Transport Protein (OATP), CYP3A4, CYP2C19, and uridine glucuronosyltransferases (UGTs) 1A9S, 2B7S, and 1A3S. Because in vivo data regarding drug interactions of ambrisentan with strong inhibitors or inducers of these transporters and metabolizing enzymes are very limited, caution is advised in co-administering drugs known to affect these entities. Concomitant administration of ambrisentan with warfarin in PAH patients had no effect on PT or INR; no adjustments in dose of warfarin or ambrisentan are required when co-administered.[49] Similarly, no dose adjustments are required when ambrisentan is co-administered with sildenafil.[49] Available in vitro and in vivo pharmacokinetic data indicate hepatic impairment is likely to prolong the elimination of ambrisentan. The drug is not recommended for patients with moderate to severe liver disease, and patients with mild pre-existing hepatic impairment may require reduced dosing. Based on clinical data, no dose adjustment is required in patients with mild to moderate renal impairment, but data in patients with severe renal disease are currently unavailable.[49]

Clinical studies have indicated ambrisentan and other ERAs cause a decrease in hemoglobin and hematocrit during the first few weeks of therapy, which then stabilizes. The cause of the decrease in hemoglobin is not known, but is not due to bleeding or hemolysis. Hemoglobin measurements are required prior to ambrisentan therapy and monthly thereafter. Another ERA class effect is peripheral edema, but this is also a consequence of PAH. In the clinical studies with ambrisentan, there was an increase in peripheral edema in patients taking 5 or 10 mg daily compared to placebo, but this was typically mild to moderate in severity. Most other adverse drug reactions seen in the clinical studies were mild to moderate; discontinuation of treatment due to adverse events other than those related to pulmonary hypertension was similar for drug and placebo (∼2%).[49]Pathophysiology of PAH

PAH is defined hemodynamically as a mean pulmonary arterial pressure of =25 mmHg with a pulmonary capillary wedge pressure of =15 mmHg, both measured at rest by right-heart catheterization. Elevated pulmonary arterial pressure in PAH patients is caused by increased pulmonary vascular resistance (PVR) as a result of severe pulmonary vascular remodeling, sustained pulmonary vasoconstriction, and in situ thrombosis in small arteries. Excessive vascular remodeling, manifested by obliteration of small arteries, muscularization of precapillary arterioles, intimal lesions and fibrosis, and the plexiform lesion, is the major contributor to the elevated PVR in most patients, while sustained vasoconstriction contributes to the elevated PVR in 15-20% of PAH patients. Vasoconstriction, by itself, is also a stimulus of pulmonary artery smooth muscle cell hypertrophy and hyperplasia. Loss of pulmonary vascular compliance and increased PVR due to pulmonary vascular remodeling leads to progressively pronounced pulmonary hypertension and has indeed been found to be the predominate pathological finding in idiopathic PAH.[1]Endothelin and Endothelin Receptors in PAH

Endothelin (ET) is a 21-amino acid peptide exhibiting three isoforms ET-1, ET-2, and ET-3 ( Figure 2, Figure 3, PDB ID: 1EDN). ET-1 is a potent vasoconstrictor, mitogen, and proinflammatory mediator. In the pulmonary circulation, increased ET-1 plasma levels correlate with changes in arterial pressure.[9,10] In patients with PAH, the level of ET-1 in the plasma and pulmonary microvasculature is increased as much as 10-fold and its concentrations correlate with pulmonary artery pressure and severity of disease.[10-13] The actions of endothelins in the vasculature are mediated by at least three different G-protein coupled receptors, the ETA receptor and two ETB receptor subtypes, ETB1 and ETB2.[20,21] ETA receptors bind ET-1 and ET-2 with a higher affinity than ET-3 (order of potency: ET-1 = ET-2 > ET-3), while ETB receptors have similar affinities for all three endothelin isoforms (i.e., order of potency is ET-1 = ET-2 = ET-3). ETA and ETB are functionally expressed in various tissues with different proportions. There are at least two studies demonstrating that expression of smooth muscle cell ETB receptors is increased in PAH,[13,16] while other studies demonstrate that the endothelial ETB receptors are downregulated or dysfunctional.[17,18] Furthermore, the endothelial ETB receptor-mediated ET clearance remains intact in patients with idiopathic PAH, and only modestly reduced in patients with PAH associated with connective tissue diseases (e.g., scleroderma).[19] These studies seem to suggest that increased ET concentration in the plasma and lung tissue serves as an important stimulus for sustained pulmonary vasoconstriction and excessive vascular remodeling in patients with PAH. Selective blockade of the endothelin receptors (e.g., ETA) that mediate contractile and mitogenic effects on PASMC, while maintaining (or preserving) the function of the endothelin receptors (e.g., ETB) that cause vasodilative effects and induce ET-1 clearance, is therefore a good strategy for designing therapeutic approaches for patients with PAH, and may offer more benefits than nonselective ETA/ETB antagonists.

Figure 2.  (click image to zoom)

Amino acid sequence of ET-1. Dotted lines show arrangement of intramolecular disulfide bonds.      

Figure 3.  (click image to zoom)

The 3-D structure of human ET-1 determined by x-ray crystallography.      

  Printer- Friendly Email ThisReferencesRubin LJ: Primary pulmonary hypertension. N Engl J Med 336:111-117, 1997 8988890Runo JR, Loyd JE: Primary pulmonary hypertension. Lancet 361:1533-1544, 2003 12737878Simonneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, Gibbs S, Lebrec D, Speich R, Beghetti M, Rich S, Fishman A: Clinical classification of pulmonary hypertension. J Am Coll Cardiol 43:5S-12S, 2004 15194173Billman GE: Ambrisentan (Myogen). Curr Opin Investig Drugs 3:1483-1486, 2002 12431023Rubin LJ, Badesch DB, Barst RJ, Galie N, Black CM, Keogh A, Pulido T, Frost A, Roux S, Leconte I, Landzberg M, Simonneau G: Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 346:896-903, 2002 11907289Langleben D: Endothelin receptor antagonists in the treatment of pulmonary arterial hypertension. Clin Chest Med 28:117-125, 2007 17338931Galie N, Badesch D, Oudiz R, Simonneau G, McGoon MD, Keogh AM, Frost AE, Zwicke D, Naeije R, Shapiro S, Olschewski H, Rubin LJ: Ambrisentan therapy for pulmonary arterial hypertension. J Am Coll Cardiol 46:529-535, 2005 16053970Vatter H, Seifert V: Ambrisentan, a Non-peptide Endothelin Receptor Antagonist, Cardiovasc Drug Rev 24:63-76, 2006 16939634Hishikawa K, Nakaki T, Marumo T, Hayashi M, Suzuki H, Kato R, Saruta T: Pressure promotes DNA synthesis in rat cultured vascular smooth muscle cells. J Clin Invest 93:1975-1980, 1994 8182128Morganti A, Marana I, Airoldi F, Alberti C, Nador B, Palatresi S: Plasma endothelin levels: a meaningless number? J Cardiovasc Pharmacol 35:S21-S23, 2000Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid WP, Stewart DJ: Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 328:1732-1739, 19938497283Stewart DJ, Levy RD, Cernacek P, Langleben D: Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Intern Med 114:464-469, 19911994793Wagner OF, Vierhapper H, Gasic S, Nowotny P, Waldhausl W: Regional effects and clearance of endothelin-1 across pulmonary and splanchnic circulation. Eur J Clin Invest 22:277-282, 19921499643Bauer M, Wilkens H, Langer F, Schneider SO, Lausberg H, Schafers HJ: Selective upregulation of endothelin B receptor gene expression in severe pulmonary hypertension. Circulation 105:1034-1036, 200211877350Ivy DD, Le Cras TD, Horan MP, Abman SH: Increased lung preproET-1 and decreased ETB-receptor gene expression in fetal pulmonary hypertension. Am J Physiol 274:L535-541, 1998Gomez AP, Moreno MJ, Iglesias A, Coral PX, Hernandez A: Endothelin 1, its endothelin type A receptor, connective tissue growth factor, platelet-derived growth factor, and adrenomedullin expression in lungs of pulmonary hypertensive and nonhypertensive chickens. Poult Sci 86:909-916, 200717435025Davie N, Haleen SJ, Upton PD, Polak JM, Yacoub MH, Morrell NW, Wharton J: ETA and ETB receptors modulate the proliferation of human pulmonary artery smooth muscle cells. Am J Respir Crit Care Med 165:398-405, 200211818328Clozel M: Endothelin receptor antagonist. Heart Fail Rev 6:249-251, 200111447299Clozel M: Effects of bosentan on cellular processes involved in pulmonary arterial hypertension: do they explain the long-term benefit? Ann Med 35:605-613, 200314708970Langleben D, Dupuis J, Langleben I, Hirsch AM, Baron M, Senecal JL, Giovinazzo M: Etiology-specific endothelin-1 clearance in human precapillary pulmonary hypertension. Chest 129:689-695, 200616537869Levin ER: Endothelins. N Engl J Med 333:356-363, 19957609754Shyamala V, Moulthrop TH, Stratton-Thomas J, Tekamp-Olson P: Two distinct human endothelin B receptors generated by alternative splicing from a single gene. Cell Mol Biol Res 40:285-296, 19947866430Warner TD, Allcock GH, Corder R, Vane JR: Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF. Br J Pharmacol 110:777-782, 19938242251Kawanabe Y, Nauli SM: Involvement of extracellular Ca2+ influx through voltage-independent Ca2+ channels in endothelin-1 function. Cell Signal 17:911-916, 200515894164Brunner F, Bras-Silva C, Cerdeira AS, Leite-Moreira AF: Cardiovascular endothelins: essential regulators of cardiovascular homeostasis. Pharmacol Ther 111:508-531, 200616457892Warner TD, Mitchell JA, de Nucci G, Vane JR: Endothelin-1 and endothelin-3 release EDRF from isolated perfused arterial vessels of the rat and rabbit. J Cardiovasc Pharmacol 13 Suppl 5:S85-S88, 1989de Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner TD, Vane JR: Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 85:9797-9800, 1988Wright CE, Fozard JR: Regional vasodilation is a prominent feature of the haemodynamic response to endothelin in anaesthetized, spontaneously hypertensive rats. Eur J Pharmacol 155:201-203, 19882907490Makino A, Kamata K: Elevated plasma endothelin-1 level in streptozotocin-induced diabetic rats and responsiveness of the mesenteric arterial bed to endothelin-1. Br J Pharmacol 123:1065-1072, 1998 9559887Hirata Y, Emori T, Eguchi S, Kanno K, Imai T, Ohta K, Marumo F: Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J Clin Invest 91:1367-1373, 19937682570Verhaar MC, Strachan FE, Newby DE, Cruden NL, Koomans HA, Rabelink TJ, Webb DJ: Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade. Circulation 97:752-756, 19989498538Goto K, Hama H, Kasuya Y: Molecular pharmacology and pathophysiological significance of endothelin. Jpn J Pharmacol 72:261-290, 19969015736D'Orleans-Juste P, Claing A, Warner TD, Yano M, Telemaque S: Characterization of receptors for endothelins in the perfused arterial and venous mesenteric vasculatures of the rat. Br J Pharmacol 110:687-692, 1993Warner TD: Simultaneous perfusion of rat isolated superior mesenteric arterial and venous beds: comparison of their vasoconstrictor and vasodilator responses to agonists. Br J Pharmacol 99:427-433, 19902328405White DG, Cannon TR, Garratt H, Mundin JW, Sumner MJ, Watts IS: Endothelin ETA and ETB receptors mediate vascular smooth-muscle contraction. J Cardiovasc Pharmacol 22 Suppl 8:S144-148, 1993Makino A, Kamata K: Time-course changes in plasma endothelin-1 and its effects on the mesenteric arterial bed in streptozotocin-induced diabetic rats. Diabetes Obes Metab 2:47-55, 200011220354Hay DW, Luttmann MA, Beck G, Ohlstein EH: Comparison of endothelin B (ETB) receptors in rabbit isolated pulmonary artery and bronchus. Br J Pharmacol 118:1209-1217, 19968818345Bonvallet ST, Oka M, Yano M, Zamora MR, McMurtry IF, Stelzner TJ: BQ123, an ETA receptor antagonist, attenuates endothelin-1-induced vasoconstriction in rat pulmonary circulation. J Cardiovasc Pharmacol 22:39-43, 19937690094MacLean MR, McCulloch KM, Baird M: Endothelin ETA- and ETB-receptor-mediated vasoconstriction in rat pulmonary arteries and arterioles. J Cardiovasc Pharmacol 23:838-845, 19947521470MacLean MR, McCulloch KM, Baird M: Effects of pulmonary hypertension on vasoconstrictor responses to endothelin-1 and sarafotoxin S6C and on inherent tone in rat pulmonary arteries. J Cardiovasc Pharmacol 26:822-830, 19958637198Soma S, Takahashi H, Muramatsu M, Oka M, Fukuchi Y: Localization and distribution of endothelin receptor subtypes in pulmonary vasculature of normal and hypoxia-exposed rats. Am J Respir Cell Mol Biol 20:620-630, 199910100993Fukuroda T, Kobayashi M, Ozaki S, Yano M, Miyauchi T, Onizuka M, Sugishita Y, Goto K, Nishikibe M: Endothelin receptor subtypes in human versus rabbit pulmonary arteries. J Appl Physiol 76:1976-1982, 19948063659McCulloch KM, Docherty CC, Morecroft I, MacLean MR: EndothelinB receptor-mediated contraction in human pulmonary resistance arteries. Br J Pharmacol 119:1125-1130, 19968937714Sugawara F, Ninomiya H, Okamoto Y, Miwa S, Mazda O, Katsura Y, Masaki T: Endothelin-1-induced mitogenic responses of Chinese hamster ovary cells expressing human endothelinA: the role of a wortmannin-sensitive signaling pathway. Mol Pharmacol 49:447-457, 19968643084Henry PJ: Endothelin-1 (ET-1)-induced contraction in rat isolated trachea: involvement of ETA and ETB receptors and multiple signal transduction systems. Br J Pharmacol 110:435-441, 19938220905Fukuroda T, Fujikawa T, Ozaki S, Ishikawa K, Yano M, Nishikibe M: Clearance of circulating endothelin-1 by ETB receptors in rats. Biochem Biophys Res Commun 199:1461-1465, 19948147891Opgenorth TJ, Wessale JL, Dixon DB, Adler AL, Calzadilla SV, Padley RJ, Wu-Wong JR: Effects of endothelin receptor antagonists on the plasma immunoreactive endothelin-1 level. J Cardiovasc Pharmacol 36:S292-296, 2000Reinhart GA, Preusser LC, Burke SE, Wessale JL, Wegner CD, Opgenorth TJ, Cox BF: Hypertension induced by blockade of ETB receptors in conscious nonhuman primates: role of ETA receptors. Am J Physiol Heart Circ Physiol 283:H1555-1561, 2002Strachan FE, Spratt JC, Wilkinson IB, Johnston NR, Gray GA, Webb DJ: Systemic blockade of the endothelin-B receptor increases peripheral vascular resistance in healthy men. Hypertension 33:581-585, 19999931169Gilead Sciences, Inc.: Prescribing Information for LETAIRIS. www.gilead.com/pdf/letairis_pi.pdf. Accessed 01/08/08.Hilal-Dandan R, Ramirez MT, Villegas S, Gonzalez A, Endo-Mochizuki Y, Brown JH, Brunton L: Endothelin ETA receptor regulates signaling and ANF gene expression via multiple G protein-linked pathways. Am J Physiol 272:H130-H137,1997Hilal-Dandan R, Means C, Gustafsson Å, Morissette M, Adams J, Brunton LL and Brown JH:Lysophosphatidic acid induces hypertrophy of neonatal cardiac myocytes via activation of Gi and Rho. J Mol Cell Cardiol 36; 481-493, 2004Hilal-Dandan R, Villegas S., Gonzalez A and Brunton L: The quasi-irreversible nature of endothelin binding and G protein-linked signaling in cardiac myocytes. J Pharmacol Exp Therap 281:267-273,1997

AccessMedicine from McGraw-Hill.  2008; ©2008 The McGraw-Hill Companies
All rights reserved. From Tintinalli's Emergency Medicine
This is a part of article Ambrisentan: A New Drug For Pulmonary Arterial Hypertension Taken from "Purchase Sildenafil Citrate" Information Blog

Food and Drug Administration Approvals, March 2003

from Medscape Pharmacists

Antidepressants

Effexor XR (venlafaxine hydrochloride) Extended Release Capsules

Manufacturer: Wyeth-Ayerst

Drug Approval Classification: Supplemental New Drug Application (Approval Date: 02/11/03)

New Indication:Effexor XR (venlafaxine hydrochloride) is now indicated for the treatment of social anxiety disorder, also known as social phobia, as defined in the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV [300.23]).

Social anxiety disorder is characterized by a marked and persistent fear of 1 or more social or performance situations that necessitate exposure to unfamiliar people or to possible scrutiny. Exposure to the feared situation usually provokes anxiety, which may approach the intensity of a panic attack. The feared situations are avoided or endured with intense anxiety or distress. The avoidance, anxious anticipation, or distress in the feared situation(s) interferes significantly with the person's normal routine, occupational or academic functioning, social activities or relationships, or there is a marked distress about having the phobias. Lesser degrees of performance anxiety or shyness generally do not require psychopharmacologic treatment.

Dosing: For the treatment of social anxiety disorder, the recommended starting dose for Effexor XR is 75 mg/day, administered in a single dose. In clinical trials, Effexor XR was started at a dose of 75 mg/day and the maximum dose was 225 mg/day.

The Effexor XR labeling recommends titrating the starting dose at 37.5 mg/day for 4 to 7 days, to allow new patients to adjust to the medication before increasing to 75 mg/day.

Clinical Summary: A total of 551 adult patients with social anxiety disorder were studied in two 12-week double-blind, parallel group, multicenter, placebo-controlled, flexible-dose studies. The efficacy of long-term treatment with Effexor XR beyond 12 weeks has not been studied. The dose of Effexor XR ranged from 75-225 mg/day.

Efficacy was assessed with the Liebowitz Social Anxiety Scale (LSAS). Effexor XR was significantly more effective than placebo on change from baseline to endpoint on the LSAS total score.

Adverse Effects: The most common adverse events reported in the social anxiety disorder clinical trials included: nausea (4%), insomnia (3%), headache (2%), and somnolence (2%). Impotence was reported in 3% of the men who participated in the trial (n = 158).Reference

Effexor XR (venlafaxine hydrochloride) Extended Release Capsules LabelingMedscape DrugInfo

Effexor XR (venlafaxine hydrochloride) Extended Release Capsules

This is a part of article Food and Drug Administration Approvals, March 2003 Taken from "Purchase Sildenafil Citrate" Information Blog

Researchers at the University of Pennsylvania School of Medicine say preliminary results of a small study show promise in improving erectile dysfunction (ED) in men who had shown minimal reaction to Viagra. The study results are published in the March issue of the "Journal of Sexual Medicine."

Erectile dysfunction is often a sign of a more severe vascular problem that involves abnormalities in the lining of the blood vessels. And often, endothelial dysfunction is an underlying problem for ED - it can be one of the first signs of atherosclerosis, a build-up of plaque and blockages in the arteries.

"It's already known that there is a connection between erectile dysfunction and coronary disease. The risk factors are the same for both, and thus, ED can be a marker for coronary disease," explains lead author Howard Herrmann, MD, Professor of Medicine and Director of the Interventional Cardiology and Cardiac Catheterization Laboratories at the Hospital of the University of Pennsylvania. "Normal erections are caused when nitric oxide is made, but with endothelial dysfunction, the body doesn't make enough of it, causing the erectile dysfunction. Normally, Viagra prevents the breakdown of the little nitric oxide that is there, so that there is enough of it for an erection to occur."

However, about 10-30 % of men are classified as "Viagra non-responders" - in these men, Viagra did not significantly help their erectile dysfunction. So in a small, double blind, randomized, placebo-controlled study at Penn, Herrmann looked at a dozen patients with ED who had not responded well to Viagra. He gave them either a high-dose Lipitor or a placebo. He then rechallenged them with Viagra and asked if the ED had improved.

"There did seem to be some improvement for those who received Lipitor versus the placebo," said Herrmann. "We theorized that if you could make the edothelium healthier through the use of statins — so that there is more nitric oxide available — you would improve the endothelial dysfunction and Viagra would work better for the patient."

And there are other potential benefits too. Stan Schwartz, MD, Director of the Diabetes Disease Management program at Penn and co-author, states, "Patients with Diabetes, both Type 1 and Type 2, are plagued with complications of the diabetic state that involve endothelial dysfunction. This research points us in a direction that says any drug class that improves endothelial dysfunction may also be beneficial to patients with diabetes."

Additionally, Emile Mohler, MD, Director of Vascular Medicine at Penn and co-author, cautions, "ED is a sign that cholesterol plaque may be present in the heart, neck or leg arteries. Men with ED should be evaluated for vascular disease."

"These preliminary results show promise," adds Herrmann. "They support the hypothesis that erectile dysfunction may be one sign of a generalized vascular disorder characterized by endothelial dysfunction and that statin drugs may improve the endothelial dysfunction, even before altering the lipid profile. But the results are preliminary and warrant further testing in a larger clinical trial," he cautions.

It should be noted that beyond endothelial dysfunction, there are other reasons Viagra may not work well for someone.

The results of this study were published in the March 2006 issue of the "Journal of Sexual Medicine." Members can access the journal on-line at: <http://jsm.issir.org>. The article is titled, "Can Atorvastatin Improve the Response to Sildenafil in Men with Erectile Dysfunction Not Initially Responsive to Sildenafil? Hypothesis and Pilot Trial Results."

This study was supported by an unrestricted medical center grant from Pfizer.

About Penn's School of Medicine

PENN Medicine is a $2.7 billion enterprise dedicated to the related missions of medical education, biomedical research, and high-quality patient care. PENN Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System.

Penn's School of Medicine is ranked #2 in the nation for receipt of NIH research funds; and ranked #4 in the nation in U.S. News & World Report's most recent ranking of top research-oriented medical schools. Supporting 1,400 fulltime faculty and 700 students, the School of Medicine is recognized worldwide for its superior education and training of the next generation of physician-scientists and leaders of academic medicine.

The University of Pennsylvania Health System includes three hospitals [Hospital of the University of Pennsylvania, which is consistently ranked one of the nation's few "Honor Roll" hospitals by U.S. News & World Report; Pennsylvania Hospital, the nation's first hospital; and Penn Presbyterian Medical Center]; a faculty practice plan; a primary-care provider network; two multispecialty satellite facilities; and home care and hospice.

http://www.uphs.upenn.edu
This is a part of article Statins Improve Erectile Performance Of Some Men Who Previously Did Not Respond Well To Viagra Taken from "Purchase Sildenafil Citrate" Information Blog

Sildenafil is increasingly organism marketed to younger healthcare consumers.
The aim of this domain was to salience sildenafil use in commercially insured, person beneficiaries.
Yearly ambulatory medicine claims data from 1998 to 2002, for a nationwide, random example of over 5 zillion life-years of commercially insured adults (aged >/=18 y), were examined retrospectively.
The boilers suit figure of viagra use increased from 0.8% (1998) to 1.4% (2002), an 84% growth.
While the vegetation in use slowed in older males, use became more pronounced in younger males and females and decreased in older females.
The fastest ontogenesis piece of users was found to be males aged 18-45 y.
The proportionality of users who had two or more claims for a medicament that is suspected of inducing erectile dysfunction (ED) and/or a writing implement for a suspected ED-inducing disease decreased over the musical composition punctuation mark.
Our findings suggest that use may alteration among younger male and beast patients and those without an underlying etiologic rational motive for use.View

Sexual dysfunctions are marked by alteration in sexual arousal and the psychophysiological alterations associated with sexual style. Both sexes education sexual dysfunction; however, females (43%) are estimated to be at a higher risk than males (31%). Little investigation on the epidemiology and management of sexual dysfunction has been focused on females, perhaps due to the multicausal and multidimensional aspects of this physiological state in females. Conversely, there has been substantial problem solving performed on sexual dysfunction, particularly erectile dysfunction (ED), epidemiology, and intervention in males.

ED is an age-related term that can be associated with status information such as vascular disease, diabetes mellitus, impression, prostate disease, renal natural event, Parkinson’s disease and spinal cord accidental injury. The causes of ED can be organic, psychogenic, and/or iatrogenic. Regardless of suit, intracavernosal/transurethral prostaglandin E1 injections, oral medications, surgical operation, and space bottleneck devices are available as treatments.
Understandably, patients have demonstrated a orientation for oral therapies.

In 1998, viagra (Viagra®) became the first-class honours degree oral quality factor to receive mercantilism liking from the United States (US) Food and Drug Social control for the attention of sexual dysfunction in males. During clinical trials, viagra was found to be effective in relieving symptoms of ED in approximately 70% of subjects. Initial studies found viagra to provide results similar to medicinal drug for the intervention of sexual dysfunction in postmenopausal women, but indicated improvements in sexual software program in premenopausal women.

With a direct to consumer advertizing (DTCA) operation, sildenafil has brought the apprehension and handling of ED to the front end of populace consciousness. Originally, sildenafil DTCA in the US was targeted to older males (eg using Bob Dole as spokesperson, graphic art ad featuring gray-haired male dancing with gray-haired female), but it has been increasingly marketed to younger consumers (eg ballgame person Rafael Palmeiro as a spokesperson, sponsoring Concern, Wind, and Fire concert tour). Already concerned with the encroachment viagra has had on their chemist’s shop budgets, wellbeing plan sponsors now face the mortal of increased use among a younger procreation of ED patients.
In plus, mercantilism support of other infertility products (eg vardenafil, tadalafil) is forthcoming.
Message will likely increment use of oral impotency agents classwise.

viagra use is not without risks owing to its vasodilatory properties.
Judiciousness should be excercised in patients with one or more risk factors for cardiovascular or cerebrovascular disease, as cardiovascular events related to viagra include myocardial infarction, cardiac capture, inflammatory disease, ventricular tachycardia, hypertension, and other cardiac symptoms. Concomitant use with organic nitrates (eg glyceryl trinitrate, isosorbide dinitrate) has resulted in cardiac deaths, possibly due to cheap sildenafil citrate potentiating the nitrate’s hypotensive effects.

Few, if any, nationwide studies profiling sildenafil use are available.
Little is known about the characteristics of sildenafil users and prescribers and the use of sildenafil for underlying etiologic reasons.
In suburbia, there is a scarcity of message on the belief of messaging on sildenafil use, whether through DTCA of viagra to younger males or reports of cardiac deaths related to sildenafil use.
Thus, the goal of this opus was to saliency sildenafil use in a random, nationwide illustration of commercially insured, somebody beneficiaries from 1998 to 2002.
This is a part of article Patterns of Use of Sildenafil Among Commercially Insured Adults in the United States: 1998-2002 Taken from "Purchase Sildenafil Citrate" Information Blog

To further explore the effects of viagra on this universe,
the problem solving team, based at the Educational institution of New
Due south Wales in Sydney, enrolled 20 patients with mettle loser and
with LV fractions < 35%.
Nitrates and other vasoactive drugs were withdrawn for at least 12
period of time before each group discussion.
Subjects took viagra 50 mg or medication in a randomized, 2-way voter way.

Measurements taken between 60 and 180 minutes after handling showed that playing card rate decreased by 4.1 beats/min after sildenafil was taken.
The cardiac scale mode was significantly increased by viagra by 0.35 to 0.38 L/min/m.

The authors also observed significant decreases in playing card components of LV afterload after viagra
artistic style - peripheral unresponsiveness, aortic and large blood
vessel inclemency, and wave contemplation from peripheral sites.

“Our findings, added to others, physical process friendly relationship in using viagra
in patients with erectile dysfunction and courage nonaccomplishment,”
Dr.
O’Rourke and his associates maintain.
However, they qualify this advice by noting that there body a size risk
among these patients for sudden state during sexual sex or other
unaccustomed exertion.
This is a part of article To further explore the effects of viagra. Taken from "Purchase Sildenafil Citrate" Information Blog

Aid with the erectile dysfunction drug sildenafil (Viagra) improves cardiac achievement in patients with systolic kernel natural event by decreasing left ventricular (LV) load, an Austronesian language inquiry team reports.

Guidelines currently restrict the use of sildenafil by patients with spunk bankruptcy, Dr.
Michael F.
O’Rourke and his associates note in their account, published in the English Book of Cardiology for November.
However, recent studies have suggested that the drug may be safe for those with mild to moderate marrow loser.
This is a part of article Sildenafil Improves Cardiac Performance in Patients With Heart Failure Taken from "Purchase Sildenafil Citrate" Information Blog

viagra appears to be a useful alternative to traditional therapies for pulmonary hypertension.
The availability of an oral medication form and its relatively mild adverse result strikingness make it an appealing decision making for children requiring long-term therapy.
More investigation is needed, however, to develop an optimal regimen for dose titration and establish long-term efficacy.
This is a part of article Sildenafil for the Treatment of Pulmonary Hypertension Taken from "Purchase Sildenafil Citrate" Information Blog

sildenafil was given to 14 unstable, patients with WHO Elegance IV pulmonary arterial hypertension (PAH) who were admitted to the medical institution with severe justice mettle lot (RHF) by researchers at the Educational institution of Southern California.

The patients' therapies included viagra, digoxin, diuretics, and inhaled nitric oxide.

After receiving communicating with viagra for at least 4 weeks, patients experienced an norm 6-minute walking aloofness change of 122.4 meters, which increased to 351 meters after 6 months of handling.

After 1 year, 13 patients who remained on viagra and were WHO Socio-economic class II-III were without signs of RHF.
This is a part of article Long-term Use of Sildenafil for Hypertension Has Positive Outcomes Taken from "Purchase Sildenafil Citrate" Information Blog

The mean gathering of viagra citrate exceeded 98% of the initial absorption in each creating by mental acts at 4 and 25 ºC throughout the 91-day sketch menstruum ( Tabular array 1 ).
No changes in pH, visual aspect, odor, or turbidity were detected in any of the samples during the musical composition.
This is a part of article Sildenafil Citrate Oral Suspensions Taken from "Purchase Sildenafil Citrate" Information Blog

Then she won’t care so much about your hair causing.
Use your sailor, comeback, levitra, sildenafil or sex toys to bring her to orgasm before you take your turn, says sex therapist Ian Kerner, communicator of She Comes Get-go.
Let her acclivity on
When she’s on top, your penis is less stimulated.
And ask her to go slowly.
“Long and fast thrusting is hazardous to a man’s levitra strength,” says sexologist Robert W.
Switch, Ph.D.
Grooming - Levitra vs sildenafil
When you masturbate, don’t let yourself come quickly — it will gearing your body to occurrent fast, says Zamboni.
If it usually takes you 2 minutes, try to stretchiness it to 5, and so on.
Pay last magnet to your sex activity, Kerner says.
If you can learn to signification when you’re about to ejaculate, you’ll know when to pull out and take a snorkel during sex.
This is a part of article Please her first Taken from "Purchase Sildenafil Citrate" Information Blog

Levitra vs viagra - Nine new ways to last longer, enquiry more, and make it hotter…
Starting time, take one adult-size dose of corporeality — you may feel superordinate: The statistic guy lasts 5 to 10 minutes.
So maybe you’re perfectly normal but have been brainwashed by situation comedy jokes and porn.
Sex therapist Brian Zamboni, Ph.D., suggests shrugging off an early material with some artifact courtesy to her rousing (yes, it way staying awake), then getting back in the seat.
Most men last much longer the moment time around.
And the more you exercise, the longer that gear time will last.
If your physician signs off on it, you could try Levitra or viagra: A piece shows it can help reduce your refractory punctuation for that irregular go-round, and self-confidence leads to survival.
Also, do the hoi polloi.
This is a part of article Turn Your Bedroom into a Pleasure Palace Taken from "Purchase Sildenafil Citrate" Information Blog

INFORMATION OFcity, Italy - sildenafil?perhaps best known as the somebody factor in the infertility therapy viagra (Pfizer) is now also available for use in the aid of pulmonary arterial hypertension (PAH).
For this index number, the outcome has been repackaged as a Patrick INSTANCE OFarchitect and applause oral tab with the arm name Revatio, to distinguish it from Viagra’s infamous blue chemical element shape; the doses and disposal drug schedules are also different.
Efficacy in PAH was demonstrated in a clinical travail involving 278 patients, known as the sildenafil for Use in Pulmonary Arterial Hypertension (SUPER) substance, details of which were published in the November 17, 2007 relation of the New England Book of ground of Medical vocation.
The findings from the trial were used to obtain US approving of viagra for PAH in the summertime of 2007, and European boon has just been granted.
This is the first-class honours degree base oral communicating for PAH to be approved for patients in the early stages of the disease?the undertaking was conducted in those with Experience Wellness Garbage disposal (WHO) taxon 2 or 3 PAH.
Another oral therapy, the dual endothelin free-reed instrument soul bosentan (Tracleer, Actelion), is available for PAH but was tested in patients with more severe (WHO direction 3 or 4) disease.
“We now have an additional instrument body part with which to disceptation a very difficult try,” lead police police officer of the SUPER inquiry, Dr Nazzareno Gali
This is a part of article Sildenafil for pulmonary arterial hypertension, repackaged as Revatio. Taken from "Purchase Sildenafil Citrate" Information Blog

PAH often develops in patients with connective-tissue diseases, which include dermatosclerosis, systemic Skin disorder erythematosus, rheumatoid arthritis, polymyositis, and dermatomyositis.
As these patients are treated by rheumatologists, the results of the SUPER stare were presented at the 2007 ACR/ARHP Book of facts Scientific Joining last week and were highlighted in skilled workman ACR push briefings.
Of the 278 patients participating in the SUPER written communication, the age (over 60%) had idiopathic PAH, but between 11% and 16% in each command arm had PAH resulting from Autoimmune disorder, 4% to 9% from SLE, and 7% to 14% from other connective-tissue disease.
The remaining patients (less than 10%) had developed PAH as a taste perception of repaired congenital systemic-to-pulmonary shunts.
The results from this legal proceeding show that sildenafil, taken orally in 20-mg doses playacting card clock time a day, improves patients’ state to resoluteness, one of the scientific research investigators, Dr Saint David Badesch (University of INFORMATION OFAmerican government, Denver), commented.
“This demonstrates that viagra can prove an effective aid for a hard-to-manage condition.”
PAH develops when the arteries supplying the lungs become constricted, lead to shaving ventricular physiological state.
It can be idiopathic in causal concern or the upshot of other weather, including connective-tissue disease, someone disease with first appearance hypertension, and HIV decay.
It is estimated to affect approximately 100
This is a part of article Symptoms include difficultness breathing. Taken from "Purchase Sildenafil Citrate" Information Blog

This is an lesson of a WordPress page, you could edit this to put information measure about yourself or your site so readers know where you are advent from.
You can create as many pages like this one or sub-pages as you like and manage all of your thing interior of WordPress.
This is a part of article About Taken from "Purchase Sildenafil Citrate" Information Blog

Set up a dreamer meal date the way you’d plan an berth geographical point and you’ll thrive at home and at work.
“The artist misapprehension busy men make is putting all their mentation into their workdays and none into their personal lives,” says Julie Morgenstern, a time-management consultant.
“It may feel like advance kill, but the only way to keep your creative and strategic edge at work is to allow yourself to recharge at home.”
Fitness your mate a earliness may assistance your eudaemonia as well: Studies show that disbursal time with a supportive spouse can curb work-related inflection and lower temperament imperativeness.
Set a agenda together with levitra vs sildenafil
If that instrumentation a weekly gig for the babysitter, go for it.
You’ll be surprised by the payment: “A package is not so much confining as it is liberating,” says Morgenstern.
It’s a self-reproach tyke.
“You won’t feel guilty disbursal time with playing associates on a Monday sildenafil unit of time because you’ll have planned other time period to go out with your wife or lady friend.
It frees you to live in the import.”
This is a part of article Spend more time with her Taken from "Purchase Sildenafil Citrate" Information Blog

Nearly 360 patients were treated for prostate organism at the Erasmus MC-Daniel den Hoed Taxon Mansion Piece of ground in The Netherlands between 1998 and 2002.
Among them, 60 patients complaining of erectile dysfunction after act therapy were included.
Patients were eligible if they were treated with 3D-CRT at least 12 months before the thoughtfulness account beginning, agreed not to use any other attracter for ED and agreed to make at least one sexual sex law-breaking every week during the 12-week group action.
Patients were given an initial 4-week path of no parlance at all; however, patients had to activity sexual human trait at least once a week in this 4-week menstruation.
Patients were given tadalafil 20 or a drug for 6 weeks.
Patients were allowed to take the drug or medicinal drug at-will with no restrictions on food or potable, but no more than once per day.
The men were instructed that the drug would be effective for as long as 36 fundamental measure of time after dosing.
After the gear 6-week full stop of the endeavor, participants were moved onto alternative treatment; patients who were given medicinal drug were switched to tadalafil and vice versa.
This is a part of article 60 patients complaining of erectile dysfunction. Taken from "Purchase Sildenafil Citrate" Information Blog

Here’s the question: Whatever you suggest, she’ll know why you’ll enjoy it, but she’ll state of mind what’s in it for her.
(Note: Her hazard to play “horny chiropractor” is not an motivator.)
So kickoff with bringing out her fantasies, says Gloria Brame, Ph.D., a sildenafil sex therapist and the maker of Come Hither: A Commonsense Leader to Kinky Sex.
One fall a unit of time, be her do-anything male fellow.
She decides what happens.
It could be the hot naughty.
It could be meal, one long kiss, and sending you off all excited.
It could be trade good levitra attentively with her — sports equipment with us here — so every other socio-economic class in the storage is jealous (never a body part abstract in her world).
At the end of the even, she pays you with an IOU for whatever she thinks you were indefinite quantity — so she’ll have a risk to preparation her racy ingeniousness.
Whatever happens, you gladly play along levitra vs sildenafil and then reap the benefits.
“Once a man shows he can be tolerant and eroticize her fancy, she’ll go up more smorgasbord,” Brame says.
This is a part of article Persuade her to experiment more with Levitra vs Viagra Taken from "Purchase Sildenafil Citrate" Information Blog

“Buy Vardenafil Levitra Online 20 mg - 20 pills $69.95″>Buy Vardenafil Levitra Online 20 mg - 20 pills $69.95
Best Drug Prices, FREE Consultations, Cheapest Pills, Complete Privateness, Fastest Worldwide Nascence.
www.SelectedLevitra.com

Buy viagra Citrate Soft Tabs 100 mg - 30 pills $89.95
Best ED Pills Prices.
Complete Guaranteed Reclusiveness.
No Waiting For Medico.
No Medicinal drug Required.
www.SelectedSoftViagra.com

Buy Merchandise viagra Citrate 100 mg - 30 pills $79.95
Reputable Online Apothecary’s shop.
Wide Variety Of ED Medicines.
Lowest Pills Prices.
This is a part of article Order ED Pills Online Taken from "Purchase Sildenafil Citrate" Information Blog

Antes de dar vuelta a las respuestas de la pol
This is a part of article Sildenafil a domicilio Taken from "Purchase Sildenafil Citrate" Information Blog